7Baggers
 Novartis Acquires Avidity Biosciences to Advance RNA-Based Neuromuscular Therapies  The Healthcare Technology Report. Mon, 17 Nov 2025 13:00:51 GMT
 us$12 billion rna deal triggers sector shakeup  streetwisereports.com Fri, 14 Nov 2025 16:36:19 GMT
 TD Cowen reiterates Hold rating on Avidity Biosciences stock at $74  Investing.com Wed, 12 Nov 2025 12:29:46 GMT
 avidity biosciences stock reaches all-time high at 70.52 usd by investing.com  Investing.com Nigeria Wed, 12 Nov 2025 08:20:50 GMT
 Avidity Biosciences stock reaches all-time high at 70.52 USD  Investing.com Tue, 11 Nov 2025 20:08:24 GMT
 needham maintains avidity biosciences(rna.us) with hold rating  富途牛牛 Tue, 11 Nov 2025 10:31:00 GMT
 decoding avidity biosciences inc (rna): a strategic swot insight  GuruFocus Tue, 11 Nov 2025 05:22:14 GMT
 Avidity Biosciences Reports Increased Revenue Amid Losses  TipRanks Tue, 11 Nov 2025 04:14:58 GMT
 avidity biosciences reports q3 eps ($1.27), consensus ($1.10)  TipRanks Tue, 11 Nov 2025 01:16:50 GMT
 avidity biosciences slides on wider losses but keeps big plans  Finimize Mon, 10 Nov 2025 22:37:20 GMT
 avidity biosciences reports wider-than-expected q3 net loss  TradingView Mon, 10 Nov 2025 21:20:50 GMT
 novartis to acquire avidity biosciences for $12 billion  Global Legal Chronicle Fri, 07 Nov 2025 00:00:00 GMT

Avidity Biosciences, Inc
(NASDAQ:RNA) 

RNA stock logo

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment...

Founded: 2012
CEO: Sarah Boyce  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends